451:
22:
190:
Project BioShield
Special Reserve Fund (SRF): The fund received a $ 25 million increase. The SRF was first funded in 2004 and receives an annualized funding level of around $ 510 million since 2004. The current funding level is $ 735 million. The program creates public-private partnerships to advance
173:
The
Alliance for Biosecurity was formed in 2005. Its purpose was to build a partnership between government and private sector biotechnology and pharmaceutical companies working in the biodefense space. The Center for Biosecurity, a nonprofit multidisciplinary organization of physicians public health
185:
In 2018, Congress passed the annual Labor, Health and Human
Services, and Education appropriations bill before the end of the fiscal year for the first time in over 20 years. Congress also passed a Department of Defense appropriations bill before the end of the fiscal year for the first time in 10
177:
In April 2018, the alliance conducted a national poll about biosecurity. Seventy-three percent of the 1,612 Americans polled said they would support a congressional decision to increase funding to address biosecurity needs and capabilities. The poll was conducted, in part, to measure support for
153:
The United States faces risks to national security posed by the danger of bioterrorism or a destabilizing infectious disease pandemic. The vulnerability is considered severe because many of the vaccines and medicines that would be needed to protect people do not currently exist. The
Alliance for
207:
The
Alliance for Biosecurity is a coalition of biopharmaceutical companies and laboratory/academic partners that promotes a strong public-private partnership to ensure medical countermeasures are available to protect public health and enhance national health security. The Alliance advocates for
182:(PAHPA) is due by September 30, 2018. PAHPA is a law that improved the federal government's medical and public health preparedness for national security threats. Examples of threats include the spread of infectious diseases or chemical, biological, radiological or nuclear (CBRN) attacks.
1009:
230:- legislation that would encourage the development of medical countermeasures, including drugs, devices and preventative treatments that could be used after a biological terrorist attack or global pandemic
69:
236:(H.R. 6378) - legislation that would reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA) before its expiration on September 30, 2018. The alliance sent a letter with the
174:
professionals and scientists, was an organizer of the alliance and participates in it. Together, the two groups have provided congressional testimony and authored letters to
Congress.
158:
653:
805:
779:
892:
608:
Six Years After
Anthrax: Are We Better Prepared to Respond to Terrorism?: Hearing Before the Committee on Homeland Security and Governmental Affairs, U.S. Senate
628:
701:
154:
Biosecurity is a group of pharmaceutical and biotechnology companies that work to create preventive measures and treatments for severe infectious diseases.
197:: This program creates incentives for companies to invest in R&D in products for biodefense, because no commercial markets for such projects exist.
179:
208:
public policies and funding to support the rapid development, production, stockpiling, and distribution of critically needed medical countermeasures.
504:
951:
830:
336:
250:
The alliance also gives out awards to
Congress. For example, in October 2017 it awarded eight Members of Congress, such as Maryland Congressman
726:
484:
254:, with its "Congressional Biosecurity Champion Award," which honors elected officials who work to improve how the U.S. can prevent and fight
1004:
413:
436:
359:
237:
224:- legislation passed in the U.S. Senate that promotes innovation and efficiency in the development of new medical countermeasures
578:
527:
489:
42:
615:
246:- legislation that creates new research incentives, improves transparency, and creates "predictable and flexible contracting"
403:
879:
887:
342:
34:
191:
the development of over 50 million doses of drugs against anthrax, smallpox, botulinum toxin and radiological threats.
554:
351:
38:
290:
275:
The
Alliance for Biosecurity is made up of the following biotechnology companies and university research labs:
165:
Special
Reserve Fund (SRF) provide funding to research, develop, and procure a medicines to control epidemics.
751:
727:"Alliance for Biosecurity applauds Alexander's actions to advance the Medical Countermeasures Innovation Act"
999:
408:
315:
259:
194:
162:
943:
137:
is a consortium of companies that develop products to respond to national security threats, including
806:"Alliance for Biosecurity hails Rep. Ruppersberger's champion efforts around bioterrorism prevention"
331:
285:
424:
307:
251:
142:
104:
68:
780:"Alliance for Biosecurity applauds passage of public health emergency response bill by committee"
494:
474:
984:
435:
The alliance is a participating member of the Virtual Biosecurity Center, an initiative of the
611:
469:
394:
115:
464:
320:
280:
186:
years. The alliance supported passage of both bills. Key funding in the bills included:
456:
379:
993:
586:
919:
479:
138:
97:
854:
677:
255:
450:
446:
499:
100:
702:"Alliance for Biosecurity praises Senate passage of 21st Century Cures Act"
977:
234:
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
126:
831:"Rep. Herrera Beutler receives Alliance for Biosecurity 'champion' award"
629:"Survey reveals American majority favors increased biosecurity funding"
388:
21:
346:
371:
240:
to each member of the House of Representatives urging its passage.
31:
may have been created or edited in return for undisclosed payments
15:
1010:
Medical and health organizations based in Washington, D.C.
217:
The alliance has supported the following legislation:
159:
Biomedical Advanced Research and Development Authority
985:
Alliance for Biosecurity - Lobbying Spending Database
37:. It may require cleanup to comply with Knowledge's
878:Posillico, Elisabeth; Chaplain, Paul (2015-07-29).
178:biosecurity funding because reauthorization of the
122:
110:
91:
83:
75:
244:Strengthening Public Health Emergency Response Act
228:Medical Countermeasures Innovation Act of 2015
258:threats. In 2019, it gave this award to Rep.
8:
87:promote a strong public-private relationship
61:
555:"Alliance for Biosecurity: Company Profile"
67:
60:
180:Pandemic and All-Hazards Preparedness Act
654:"Congress Funds Key Biosecurity Efforts"
505:United States biological defense program
427:serves as secretariat for the alliance.
157:Within the U.S. federal government, the
145:. It is headquartered in Washington DC.
516:
337:Lovelace Respiratory Research Institute
914:
912:
485:Blue Ribbon Study Panel on Biodefense
7:
522:
520:
404:The Texas A&M University System
414:University of Texas Medical Branch
376:Romark Laboratories, L.C. (former)
95:National security threats such as,
14:
437:Federation of American Scientists
449:
20:
954:from the original on 2022-09-06
898:from the original on 2020-12-17
490:Congressional Biodefense Caucus
880:"HHRG-114-IF14-20160519-SD003"
127:www.allianceforbiosecurity.com
1:
944:"Participating Organizations"
888:U.S. House of Representatives
633:Congresswoman Susan W. Brooks
535:www.appropriations.senate.gov
343:Meridian Medical Technologies
332:Johnson & Johnson/Janssen
33:, a violation of Knowledge's
135:The Alliance for Biosecurity
1005:Biotechnology organizations
431:Partners and collaborations
312:Emerald Bioscience (former)
295:iBio / CC-Pharming (former)
1026:
948:Virtual Biosecurity Center
835:Homeland Preparedness News
829:Flax, Debra (2019-08-01).
810:Homeland Preparedness News
784:Homeland Preparedness News
731:Homeland Preparedness News
706:Homeland Preparedness News
610:. 2009. DIANE Publishing.
528:"Alliance for Biosecurity"
804:Riley, Kim (2017-10-23).
308:Elusys Therapeutics, Inc.
66:
859:Alliance for Biosecurity
682:Alliance for Biosecurity
658:Alliance for Biosecurity
583:Alliance for Biosecurity
418:Venatorx Pharmaceuticals
238:U.S. Chamber of Commerce
62:Alliance for Biosecurity
325:Hawaii Biotech (former)
141:pathogens and emerging
222:21st Century Cures Act
210:
409:Tonix Pharmaceuticals
356:Neumedicines (former)
316:Emergent BioSolutions
260:Jaime Herrera Beutler
205:
43:neutral point of view
286:Baxter International
606:Lieberman, Joseph.
425:Squire Patton Boggs
252:Dutch Ruppersberger
213:Legislative support
143:infectious diseases
105:infectious diseases
63:
759:docs.wixstatic.com
495:Pandemic influenza
475:Biological warfare
470:Biological hazard
395:Siga Technologies
360:Novartis Vaccines
195:Project BioShield
163:Project BioShield
132:
131:
59:
58:
1017:
981:
980:
978:Official website
963:
962:
960:
959:
940:
934:
933:
931:
930:
916:
907:
906:
904:
903:
897:
884:
875:
869:
868:
866:
865:
851:
845:
844:
842:
841:
826:
820:
819:
817:
816:
801:
795:
794:
792:
791:
776:
770:
769:
767:
766:
756:
748:
742:
741:
739:
738:
723:
717:
716:
714:
713:
698:
692:
691:
689:
688:
674:
668:
667:
665:
664:
650:
644:
643:
641:
640:
625:
619:
604:
598:
597:
595:
594:
585:. Archived from
575:
569:
568:
566:
565:
551:
545:
544:
542:
541:
532:
524:
459:
454:
453:
352:Nanotherapeutics
161:(BARDA) and the
116:Washington, D.C.
71:
64:
54:
51:
39:content policies
24:
16:
1025:
1024:
1020:
1019:
1018:
1016:
1015:
1014:
990:
989:
976:
975:
972:
967:
966:
957:
955:
942:
941:
937:
928:
926:
918:
917:
910:
901:
899:
895:
882:
877:
876:
872:
863:
861:
853:
852:
848:
839:
837:
828:
827:
823:
814:
812:
803:
802:
798:
789:
787:
778:
777:
773:
764:
762:
761:. July 27, 2018
754:
750:
749:
745:
736:
734:
725:
724:
720:
711:
709:
700:
699:
695:
686:
684:
676:
675:
671:
662:
660:
652:
651:
647:
638:
636:
627:
626:
622:
605:
601:
592:
590:
577:
576:
572:
563:
561:
553:
552:
548:
539:
537:
530:
526:
525:
518:
513:
465:9/11 Commission
455:
448:
445:
433:
421:
400:Soligenix, Inc.
281:Bavarian Nordic
273:
268:
215:
204:
171:
151:
118:
103:
96:
55:
49:
46:
41:, particularly
25:
12:
11:
5:
1023:
1021:
1013:
1012:
1007:
1002:
992:
991:
988:
987:
982:
971:
970:External links
968:
965:
964:
935:
908:
870:
846:
821:
796:
771:
743:
718:
693:
669:
645:
620:
599:
570:
546:
515:
514:
512:
509:
508:
507:
502:
497:
492:
487:
482:
477:
472:
467:
461:
460:
457:Biology portal
444:
441:
432:
429:
420:
419:
416:
411:
406:
401:
398:
392:
386:
383:
380:Sanofi Pasteur
377:
374:
369:
366:
363:
357:
354:
349:
340:
334:
329:
328:Heat Biologics
326:
323:
318:
313:
310:
305:
302:
299:
296:
293:
288:
283:
277:
272:
269:
267:
264:
248:
247:
241:
231:
225:
214:
211:
203:
200:
199:
198:
192:
170:
167:
150:
147:
130:
129:
124:
120:
119:
114:
112:
108:
107:
93:
89:
88:
85:
81:
80:
77:
73:
72:
57:
56:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
1022:
1011:
1008:
1006:
1003:
1001:
998:
997:
995:
986:
983:
979:
974:
973:
969:
953:
949:
945:
939:
936:
925:
921:
915:
913:
909:
894:
890:
889:
881:
874:
871:
860:
856:
855:"Our Members"
850:
847:
836:
832:
825:
822:
811:
807:
800:
797:
785:
781:
775:
772:
760:
753:
747:
744:
732:
728:
722:
719:
707:
703:
697:
694:
683:
679:
678:"Our Mission"
673:
670:
659:
655:
649:
646:
634:
630:
624:
621:
617:
613:
609:
603:
600:
589:on 2017-02-14
588:
584:
580:
574:
571:
560:
556:
550:
547:
536:
529:
523:
521:
517:
510:
506:
503:
501:
498:
496:
493:
491:
488:
486:
483:
481:
478:
476:
473:
471:
468:
466:
463:
462:
458:
452:
447:
442:
440:
438:
430:
428:
426:
417:
415:
412:
410:
407:
405:
402:
399:
396:
393:
390:
387:
384:
381:
378:
375:
373:
370:
367:
364:
361:
358:
355:
353:
350:
348:
344:
341:
338:
335:
333:
330:
327:
324:
322:
319:
317:
314:
311:
309:
306:
303:
300:
297:
294:
292:
289:
287:
284:
282:
279:
278:
276:
270:
265:
263:
261:
257:
253:
245:
242:
239:
235:
232:
229:
226:
223:
220:
219:
218:
212:
209:
201:
196:
193:
189:
188:
187:
183:
181:
175:
168:
166:
164:
160:
155:
148:
146:
144:
140:
136:
128:
125:
121:
117:
113:
109:
106:
102:
99:
98:bioterrorism
94:
90:
86:
82:
78:
74:
70:
65:
53:
44:
40:
36:
32:
29:This article
27:
23:
18:
17:
1000:Bioterrorism
956:. Retrieved
947:
938:
927:. Retrieved
923:
920:"WHO WE ARE"
900:. Retrieved
886:
873:
862:. Retrieved
858:
849:
838:. Retrieved
834:
824:
813:. Retrieved
809:
799:
788:. Retrieved
786:. 2016-07-21
783:
774:
763:. Retrieved
758:
746:
735:. Retrieved
733:. 2016-01-22
730:
721:
710:. Retrieved
708:. 2016-12-08
705:
696:
685:. Retrieved
681:
672:
661:. Retrieved
657:
648:
637:. Retrieved
635:. 2018-04-16
632:
623:
607:
602:
591:. Retrieved
587:the original
582:
573:
562:. Retrieved
558:
549:
538:. Retrieved
534:
480:Bioterrorism
434:
422:
274:
266:Organization
249:
243:
233:
227:
221:
216:
206:
184:
176:
172:
156:
152:
139:bioterrorism
134:
133:
50:January 2022
47:
35:terms of use
30:
304:CUBRC, Inc.
256:biosecurity
76:Established
994:Categories
958:2023-08-07
929:2022-06-21
902:2022-06-20
864:2017-02-13
840:2019-09-01
815:2017-10-25
790:2017-02-22
765:2019-06-08
737:2017-02-22
712:2017-02-22
687:2017-02-13
663:2018-11-30
639:2018-08-27
616:1437911064
593:2017-02-13
579:"Our Work"
564:2017-02-13
540:2019-06-08
511:References
271:Membership
149:Background
559:Bloomberg
500:Terrorism
423:Law firm
101:pathogens
952:Archived
924:Alliance
893:Archived
752:"Letter"
443:See also
391:(former)
385:SCYNEXIS
382:(former)
362:(former)
339:(former)
298:Chimerix
291:BioCryst
262:(R-WA).
111:Location
389:Seqirus
301:Coherus
202:Mission
169:History
123:Website
84:Mission
614:
397:, Inc.
368:Pfenex
365:Opiant
347:Pfizer
896:(PDF)
883:(PDF)
755:(PDF)
531:(PDF)
372:Roche
92:Focus
612:ISBN
79:2005
321:GSK
45:.
996::
950:.
946:.
922:.
911:^
891:.
885:.
857:.
833:.
808:.
782:.
757:.
729:.
704:.
680:.
656:.
631:.
581:.
557:.
533:.
519:^
439:.
961:.
932:.
905:.
867:.
843:.
818:.
793:.
768:.
740:.
715:.
690:.
666:.
642:.
618:.
596:.
567:.
543:.
345:/
52:)
48:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
